Sun Y, Mu G, Xue Z, Wang S, Li X,Han M*. Targeting cholesterol homeostasis through inhibiting SREBP-2: An Achilles' heel for glioblastoma.Neuro Oncol. 2023 Aug 25:noad145.
Sun Y, Mu G, Xue Z, Li X, Lin X,Han M*. Pharmacological targeting of one‑carbon metabolism as a novel therapeutic strategy for glioblastoma.J Transl Med.2023 Jun 29;21(1):424.
Yang X, Zhang Y, Xue Z, Hu Y, Zhou W, Xue Z, Liu X, Liu G, Li W, Liu X, Li X,Han M*, Wang J. TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 protein.J Exp Clin Cancer Res.2022 Dec 6;41(1):336.
Han M, Shuai Wang, Sabrina Fritah, Xu Wang, Wenjing Zhou, Ning Yang, Shilei Ni, Bin Huang, Anjing Chen, Gang Li, Hrvoje Miletic, Frits Thorsen, Rolf Bjerkvig, Xingang Li and Jian Wang. Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/β-catenin signaling.Brain. 2020, 143(2): 512-530
Han M, Shuai Wang, Ning Yang, Xu Wang, Wenbo Zhao, Halala Sdik Saed, Thomas Daubon, Bin Huang, Anjing Chen, Gang Li, Hrvoje Miletic, Frits Thorsen, Rolf Bjerkvig, Xingang Li, Jian Wang. Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma. EMBO Molecular Medicine. 2020, 12(1).
Han M*, Bin Huang, Shilei Ni, Jian Wang, Xingang Li, Rolf Bjerkvig. A validated prognostic nomogram for patients with newly diagnosed lower-grade gliomas in a large-scale Asian cohort. Neuro-Oncology. 2020. pii: noaa027.
